|
How can Statistics Facilitate the Clinical/Nonclinical Link in a Quality by Design Approach to Pharmaceutical Development?
*Darrell Abernathy, USP *Alan Hartford, Merck & Co., Inc. *Jeff Hofer, Eli Lilly *Ron Menton, Wyeth *Tom Schultz, Johnson & Johnson Keywords:
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC
